Microsoft Technology Licensing, LLC

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Haiyang Wang

Jyh-Han Lin

Ankit Srivastava

Sandeep Patnaik

Lingxiao Hang

XiWen Yue

Zhiming Zhao

Fan Yin

Chenchen Wu

Nandita Sharma

Qingqing Qi

Naga Venkata Rajagopal Ramadugu

Hu Lu

The present disclosure relates to systems, methods, and computer-readable media for receiving usage data for a virtual device (or other virtual service), analyzing the usage data to determine a usage bucket characteristic of usage of the virtual device over a period of time, and determining a usage score for the virtual device. The systems described herein further involve causing a deployment of the virtual device to be upgraded, downgraded, or otherwise modified based on the usage bucket and associated usage score. The features and functionalities described herein can provide an efficient mechanism for administrating a tenant deployment as well as implementing a more efficient utilization of cloud computing resources for a variety of virtual services.

Upgrading a virtual device deployment based on spike utilization

Provided are [1,2,4]triazol[4,3-a]pyridine derivatives as shown in the general formula (I), a preparation method therefor, and a pharmaceutical composition containing the derivative, wherein the pharmaceutical composition is used as a therapeutic agent, and especially used as a c-Met inhibitor and an immunosuppressant. Each substituent in the general formula (I) is the same as that defined in the specification. 

[1,2,4] triazol [4,3-A] pyridine derivative, preparation method therefor or medical application thereof

Growing community of inventors

Jiangsu, China

Haiyang Wang